| Ticker Details |
Repligen Corporation
Repligen Corp is a bioprocessing company developing, producing and commercializing biologic drugs. The company offers its products to life science companies, global biopharmaceutical companies, and contract manufacturers worldwide.
|
| IPO Date: |
March 26, 1990 |
| Sector: |
Healthcare |
| Industry: |
Life Sciences Tools and Services |
| Market Cap: |
$7.64B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.21 | 2.14%
|
| Avg Daily Range (30 D): |
$2.80 | 1.89%
|
| Avg Daily Range (90 D): |
$2.73 | 1.78%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.3M |
| Avg Daily Volume (30 D): |
.65M |
| Avg Daily Volume (90 D): |
.66M |
| Trade Size |
| Avg Trade Size (Sh.): |
69 |
| Avg Trade Size (Sh.) (30 D): |
43 |
| Avg Trade Size (Sh.) (90 D): |
43 |
| Institutional Trades |
| Total Institutional Trades: |
5,991 |
| Avg Institutional Trade: |
$5.11M |
| Avg Institutional Trade (30 D): |
$8.22M |
| Avg Institutional Trade (90 D): |
$8.71M |
| Avg Institutional Trade Volume: |
.05M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$7.4M |
| Avg Closing Trade (30 D): |
$12.97M |
| Avg Closing Trade (90 D): |
$14.86M |
| Avg Closing Volume: |
62.39K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$.02
|
$.27
|
$.26
|
|
Diluted EPS
|
$.02
|
$.26
|
$.26
|
|
Revenue
|
$707.89M
|
$188.81M
|
$182.37M
|
|
Gross Profit
|
$321.26M
|
$100.52M
|
$91.14M
|
|
Net Income / Loss
|
$1.74M
|
$14.91M
|
$14.87M
|
|
Operating Income / Loss
|
$.8M
|
$16.83M
|
$13.9M
|
|
Cost of Revenue
|
$386.64M
|
$88.29M
|
$91.22M
|
|
Net Cash Flow
|
$-37.55M
|
$40.08M
|
$10.64M
|
|
PE Ratio
|
6,733.50
|
|
|
|
|
|
